Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer

par Tuszynski, Jack, Tilli, Tatiana M., Levin, Michael
Publié dans Curr Pharm Des (2017)

Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an...

par Tilli, Tatiana M., Carels, Nicolas, Tuszynski, Jack A., Pasdar, Manijeh
Publié dans Oncotarget (2016)

Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines

par Tilli, Tatiana M, Bellahcène, Akeila, Castronovo, Vincent, Gimba, Etel R P
Publié 2014

A strategy to identify housekeeping genes suitable for analysis in breast cancer diseases

par Tilli, Tatiana M., Castro, Cláudio da Silva, Tuszynski, Jack A., Carels, Nicolas
Publié dans BMC Genomics (2016)

Osteopontin is a tumor autoantigen in prostate cancer patients

par TILLI, TATIANA M., SILVA, ELOÍSIO A., MATOS, LÍVIA C., FAGET, DOUGLAS V., DIAS, BIANCA F.P., VASCONCELOS, JULIANA S.P., YOKOSAKI, YASUYUKI, GIMBA, ETEL R.P.
Publié 2011

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

par Hugo de Almeida, Vitor, Guimarães, Isabella dos Santos, Almendra, Lucas R., Rondon, Araci M.R., Tilli, Tatiana M., de Melo, Andréia C., Sternberg, Cinthya, Monteiro, Robson Q.
Publié dans Oncotarget (2018)